<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 197 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page196.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=197">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 197 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 197</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=197"><img src="../thumb/197.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Respiratory System - 10.3 / 10.4 / 10.4.1                                      2020-04 / 163
       MUCOSPECT, (Aspen Pharmacare: Consum) Pharmacare [P/S]  alone: 0,25 mg 2xdly. Inhal. corticoster: 0,25 mg 2xdly. Oral corticos-  BECLATE, Cipla Medpro [PWR]
       Carbocysteine.                ter: 0,5 mg 2xdly. Maint: 0,25-0,5 mg 2xdly.  Beclomethasone dipropionate.
       Indications: Resp.tract disord.charact.by excess. mucus in ab-  Childr.6 yrs.& old: Prev.ther: Recomm.start.dos. Bronchodilat.alone:   Indications: Asthma.
       sence of infect.              0,25-0,5 mg 2xdly. Inhal. corticoster: 0,25-0,5 mg 2xdly. Oral corticos-  (S3) HFA INHALER. 38/21.5.1/0186, 37/21.5.1/0652, 0653.
       (S2) SYRUP, [P/S] L/10.1/318. 250 mg/5 ml  ter: 0,25-1 mg 2xdly. Maint: 0,25-0,5 mg 2xdly. Consid. incr.dos.if reqd.  819611-018: 50 µg/actuat., 200 met.dos., R92,48
       744816-009: 200 ml, R37,91    Pts.depend.on oral ster: Init.use concurr.with usual oral glucocor-  819638-005: 100 µg/actuat., 200 met.dos., R168,06
       Dosage: Admin. 3xdly.         ticoster.maint.dos. Reduc.oral dos. grad.aft.one wk.to low.poss.lev.   820083-003: 200 µg/actuat., 200 met.dos., R168,06
       Adults: 10-15 ml. 5-12 yrs: 5 ml.  Slow withdr. rate strong.recomm.  Dosage: Adults: Usual dos: 200 µg 2xdly.
       (S2) PAED.SYRUP, [P/S] W/10.1/216.  Ac.laryngotracheobronchit.(croup): Infts.& childr: Usual: 2 mg   Sev.cases: 600-800 µg/day reduc.when stabilis., admin. as 2-3-4 div.
       781169-003: 125 mg/5 ml, 100 ml, R36,86  nebulis.giv.as sngl.dos or 2x1 mg dos.with 30 min.interv.  dos. Sev.cases/part.respons: up to 1 mg/day in div. dos.
       Dosage: Admin. 3xdly.         Contraindications: Lung TB, airway fung.& vir. infects., safety &   Childr: 50-100 µg 2-3-4xdly accord.to age & respons.
       Childr. 2-5 yrs: 2,5-5 ml. 5-12 yrs: 10 ml.  effic.of nebulis.susp.in childr. &lt;12 mnths.not est., safety in pregn.&   Contraindications: Ac.stat.asthmatic., safety in pregn.not est.
       (S2) CAPS, [P/S] P/10.1/186.  lactat.not est.,             Side effects: Hoarsen., candidias.of mouth & throat, paradox.bron-
       744824-001: 375 mg, 30, R76,40  Side effects: Throat irrit., hoarsen., cough., oropharynx candidias.,   chosp.(discont.), adren. suppress.
       Dosage: 2 caps 3xdly red.to 1 cap 4xdly.aft. satis.respon.  nervousn., restlessn., depress., behave.disturbs., hypersens.reacts.   Special precautions: Act./quisc.pulmon.TB, re-instatem.of syst.
       Contra-indications: Pept.ulc., safety in pregn.not est.  incl. angioed., skin reacts., bronchosp., skin bruis., fac. skin irrit.when   ster.dur.stress, airway obstruct./ reduc.absorpt., transf.from syst.ster.
       Side-effects: Naus., diarrh., headache, dizz., palpits., heartburn,   nebulis.face mask used.  BUDEFLAM, Cipla Medpro [PWR]
       skin rash, GI bleed.          Special precautions: Withdr.oral corticoster. grad., poss.insuffic.  Budesonide.
       Special precautions: Gastr./duod.ulc.  corticoster.eff.if musc.& joint pain/ tiredn./headache/N & V exper.dur.  Indications: Asthma sympt.prophylax.
       Drug interactions: Incompat.with pholcod.linct.  withdr. per., oral steroid depend.pts.may req.supplem. syst. corticos-  (S3) MET.DOSE INHAL.WITH GENTLE-HALER, 30/21.5.1/0255,
       SOLMUCOL, (Aspen Pharmacare: Consum) Pharmacare   ter.dur.stress/ac.asthma attack/ elect. surg, wash face aft.using face   32/21.5.1/0115
                                     mask, rinse mouth aft.use to minim.oropharyngeal thrush, high dos.
       [P/S]                                                      897462-004: 100 µg/dos, 300 dos, R244,06
       N-acetylcysteine.             emerg.corticoster.ther./prolong.treatm.of inhal. corticoster at the high.  897469-003: 200 µg/dos, 300 dos, R348,33
                                     recomm.dos.at risk of ren. impairm., unmask.of allerg.prev.control.by
       Indications: Adjunct.therapy in resp.condits., reduc.viscos.of non-  Dosage: Admin.bronchodilat.sev.mins.bef.to minim. loc.S/E. Spacer
       infect.secret.in cyst.fibros.  syst. ster., sev.comprom.liv.funct., long term effs. not complet. known,   use recomm.in dly.adult dos. above 400 µg.& in all childr.dos.for im-
       (S1) GRANS, [P/S] 28/10.2.2/0128  monit.child.& adolesc.growth, not intend.for rapid relief of ac.asthma   prov. lung deposit. Stable asthmat: 2xdly.may be adeq. Maint.dos:
       809284-006: 200 mg, 20 sachets, R141,07  episod., re-assess treatm.if prescrib.short act.bronchodilat.no long.   Indiv.on low.poss.dos. For use even when asympt.
       (S3) GRANS, [P/S] 28/10.2.2/0129.  effect., cataract.format.induc.with long-term. treatm.  Adults & childr.over 12 yrs: 400 µg/day in div. dos. Sev.asthma:
       809292-009: 400 mg, 30 sachets, R243,58  Drug interactions: Inhibit.of cytochrome P450 may incr.sys-  Dly.dos.may be incr.to 1 600 µg /day.
       (S1) LOZ, [P/S] 28/10.2.2/0451.  tem.expos.                Childr: 100 –200 µg 2x dly. Sev.asthma: Dly.dos. may be incr.to
       809306-018: 100 mg, 24, R130,73  ASMANEX TWISTHALER, MSD [P/S]  800 µg/day
       Dosage: Dissol.gran.bef.admin.  Mometasone furoate         Contraindications: Act./quiesc.pulm.TB, untreat. bact./fung./vir.
       Resp.disords: Childr.up to 2 yrs: 200 mg dly. 2-6 yrs: 200 mg 2xdly.   Indications: Asthma prophylax.in adults & childr.over 12 yrs.  airway infects., pregn., lactat. safety not est., DP caps also: safety
       Adults: 200 mg 3xdly.         (S3) DRY POWD.INHAL., 34/21.5.1/0343, 0344  in childr. und.6 yrs.not est.
       Cyst.fibros: Childr.2-6 yrs: 200 mg 3xdly. Adults: 200-400 mg 3xdly.  717571-001: 200 µg /actuat., 30 dos, R148,98  Side effects: Loc.irrit., psych.effs., paradox. bronchoconstrict., dys-
       Contraindications: Pregn.     717572-001: 200 µg /actuat., 60 dos, R297,75  phon., bact./fung.mouth & throat infects./ dryn./bad taste of mouth &
       Side effects: GI disturbs., rhinorrh., bronchosp., chills, fev., headache,   717581-001: 400 µg /actuat., 30 dos, R196,10  throat, skin reacts., headache, GI effs., tiredn., thirst, pulmon.infiltrat.,
       tinnit., urticar., haemoptys., anaphylact.reacts.  717582-001: 400 µg /actuat., 60 dos, R392,16  poss.cataract format.aft.prolong. use, adren.suppress.
       Special precautions: Elderly with resp.insuffic., asthmat.pts., re-  Dosage: Titr.to low.effect.dos.once stabil.achiev. Do not exceed   Special precautions: Rinse mouth aft.use, transf. of oral steroid
       cent gastro-duod.ulcerat.     recomm.dos.                  pts., monit.intercurr.infects., stress, do not stop inhal.steroids abrupt.
                                     Adults & childr.over 12 yrs:  BUDONEB, (Cipla) Arrow [P/S]
                                     Prev. bronchodil.alone/prev. inhal. corticoster: Init.200 µg once   Budesonide
       10.4   Anti-asthmatics        dly in even. Max. recomm. dly.dos: 400 µg admin.in div.dos.of 200 µg   Indications: Asthma inadeq.control.by bronchodilat., pts.unable
                                                                  to use MDI/powd.form of inhal. med., ac. laryngotracheobronchit.
                                     2x dly or 400 µg once dly in even.
              No products listed     Prev. oral corticoster: Init.400 µg 2x dly with max. dly.dos.800 µg.  (croup) in infts. & childr.
                                     Sev.asthma requir.oral corticoster: Recomm. start. dos.400 µg   (S3) NEBULIS.SUSP, 42/21.5.1/0953, 0954
                                     2x dly (max.dos).Titr.to low. effect. dos.once oral steroid reduct.  721277-001: 0,25 mg/ml, 20x2 ml unit dos. amps, R200,91
       10.4.1  Glucocorticoids       compl. Max. eff. poss. not achiev.bef.1-2 wks or long. Do not ex-  721278-001: 0,5 mg/ml, 20x2 ml unit dos. amps, R289,96
                                                                  Dosage: Use only in nebulis. Not for inj. Indiv. titrat. to low.effect.
       FLIXOTIDE (MDR Listing)       ceed recomm.dos.             maint.dos.once asthma control achiev. May be mix.with 0,9% sa-
                                     Contraindications: Safety in pregn.& lactat.not est., use as a bron-
       ALVESCO, Astra Zeneca [PWR]   chodilat./rapid bronchosp.relief, safety & effic.in childr.und.12 yrs.  line & sols.of terbutaline/ salbutamol/fenoterol/ acetylycysteine/
                                                                  sod.cromoglycate or ipratropium brom. to be used within 30 mins.
       Ciclesonide.                  not est., lact. intol.       Asthma: Adults: Init. 0,5-1 mg 2xdly, may be furth.incr.in some cases.
       Indications: Asthma sympt.prophylax.in adults/ adolesc.& chil-  Side effects: Freq: Candidias., dysphon., pharyngit., headache. Less   Childr.12 mnths-6 yrs: Prev.ther: Recomm.start. dos. Bronchodilat.
       dr.6 yrs & old.               freq: Dry mouth/ throat, weight incr., dyspeps., palpitat., syst.eff.   alone: 0,25 mg 2xdly. Inhaled corticoster: 0,25 mg 2xdly. Oral corti-
       (S3) MET.DOSE INHAL. 37/21.5.1/0530, 0531  esp. dur.prolong.use incl.adren.suppress./growth retardat./ glauc./  coster: 0,5 mg 2xdly. Maint: 0,25-0,5 mg 2xdly. Childr.6 yrs.& old:
       705265-001: 80 µg, 60 met.dos, R306,16  cataracts/decr. BMD. Freq. unknown: Hypersens.incl.skin reacts./   Prev.ther: Recomm.start.dos. Bronchodilat. alone: 0,25-0,5 mg 2xdly.
       705267-001: 160 µg, 60 met.dos, R392,77  anaphylax./ angioed., asthma aggrav., blurr.vis.  Inhal.corticoster: 0,25-0,5 mg 2xdly. Oral corticoster: 0,25-1 mg 2xdly.
       705269-001: 160 µg, 120 met.dos, R785,78  Warnings and special precautions: Rinse mouth/ gargle aft.  Maint: 0,25-0,5 mg 2xdly. Consid.incr.dos.if incr. therap eff. reqd. Pts.
       Dosage: Inhalat.use only. Indiv.& titrat.to low. effect.dos.  inhal., antifung.ther./discont.in case of candidias., consid.referr.pt.to   depend.on oral ster: Init.use concurr. with usual oral glucocorti-
       Adults & adolesc: Tot.dly.dos.range: 80-320 µg admin. as sngl.  ophthalmolog. in case of vis.disturbs., not indicat. for rapid relief of   coster. maint. dos. Reduc .oral dos.grad.aft.one wk.to low.poss. lev.
       morn./even dos                bronchosp., discont.inhal.& immed. ther.with fast-act.bronchodilat.if   Slow withdr.rate recomm.
       Childr.6 yrs.& old: Recomm.dly.dos: 80-160 µg admin. in 2 div.dos.  bronchosp. occurs, transf.pts.from syst.steroids, HPA-axis funct.recov.  Ac.laryngotracheobronchit.(croup): Infts. & childr: Usual: 2 mg
       OR as sngl.morn./even dos     aft.syst.steroid withdr., dur. stress per.incl.trauma/surg./infect./sev.  nebulis.giv.as sngl.dos or 2x1 mg dos.with 30 min.interv.
       Contraindications: Safety & effic.in childr.und. 6 yrs.not est., safety   asthma attack period.adrenocort.funct.test.recomm., sens. to corti-  Contraindications: Safety in pregn. & lactat.not est., lung TB, air-
       in pregn.& lactat.not est., status asthmatic./other ac.asthma episod.   sol prod., unmask.of prev.allerg.condits. suppress. by syst.steroids,   way fung. & vir. infects., safety & effic. in childr.&lt;12 mnths.not est.
       requir. intens. ther.         report to physic.immed. if asthma episod.not repons.to bronchodil.,   Side effects: Throat irrit., hoarsen., cough., oropharyng. candidias.,
       Side effects: Paradox.bronchosp., hoarsen., cough aft.inhalat.,   ac./ quiesc. TB of resp.tract, untreat.fung./bact./syst. vir. infects./  nervousn., restlessn., depress., behav.disturbs., hypersens.reacts.
       loc. irrit., bad taste, oropharyng. Candidiasis, rash, eczema, im-  ocul.H.simpl., immunosuppress.risk expos. to infects.eg.chicken pox/  incl. angioed./ bronchosp., skin reacts.incl.bruis., fac. skin irrit. when
       med./ delay. hypersens.reacts., syst.corticoster.eff. with high dos.   measles esp. childr., cons.syst.steroid cover dur.stress/elect. surg. if   nebulis.face mask used.
       over prolong.periods          addit.syst.steroids need., withdr.grad., monit. dos.reduct., incr.syst.  Warning and special precautions: Wash face aft. using face
       Special precautions: Pts.transf.from oral steroids remain at risk of   ster.dos.tempor.& contin. withdraw.more slowly thereaft.if evid.  mask, rinse mouth aft.use to minim. oropharyng. thrush, oral steroid
       imp.adren.reserve for consid. time, sev.hepat.impairm., pulm.TB, not   of adren. insuffic.occ., dos.exceed.recomm.dos.does not incr.effic.  depend.pts.may req. supplem.syst. corticoster.dur.stress/ac.asthma
       for relief of ac.asthma sympts., pts.to keep inhal. short act. bronchodi-  Interactions: Incr.plasma conc. & risk of system. S/E with strong   attack/ elect.surg., S&S of syst.glucocorticoster. effs. incl.adren.hypo-
       lat.avail., if treatm.less effect./ requirem.incr.treatm.to be re-assess,   CYP3A4 inhibits.incl. ketoconazole/ itraconazole/clarithromycin/ ri-  funct./growth reduct.veloc. with prolong.ther., imp.ren.funct.risk dur.
       stress from emerg./elect.situat., assess risk vs. benef. of contin.use if   tonavir/ cobicistat-contain.prods.  oral ster. transf./ high dos.emerg.corticoster.ther.or prolong. ther. on
       paradoxic.bronchosp. occurs, do not stop ther.abrupt.  BECEZE, Biotech [PWR]  high.recomm.dos.if inhal.corticoster., temp. oral corticoster.dos.incr.
       Drug interactions: Poss.incr.in ser.lev.with potent inhibit.of cyto-  Beclomethasone dipropionate.  poss.need.dur. withdr. per., allerg.unmask.if syst.ther.replac.with in-
       chrome P450 3A4 syst.         Indications: Asthma.         hal., sev.comprom.liv.funct.as eliminat.poss. affect., longt.loc./syst.
       ARROW BUDESONIDE, (Teva) Actavis [P/S]  (S3) CFC FREE INHALER. 36/21.5.1/0192, 0193  effs.not known, monit.child. & adolesc.growth, not intend.for rapid
       Budesonide.                   827061-005: 50 µg, 200 met.inhalat., R85,49  relief of ac. asthma episod., re-assess treatm.if prescrib.short-act.
                                                                  bronchodilat.no long.effect./more than usual inhalat. need., cataract.
       Indications: Asthma inadeq.control.by bronchodilat., pts.unable   827088-019:: 100 µg, 200 met.inhalat., R163,67
       to use MDI/powd. form of inhal.med., ac.laryngotracheobronchit.  Dosage: Childr: 50-100 µg 2-4xdly accord.to respons.  format.induc.with long-term. treatm.
                                                                  Interactions: Inhibit.of cytochrome P450 may incr. syst. expos.
       (croup) in infts.& childr.    Adults: Init.400-800 µg dly adjust.accord.to respons. Maint: 100 µg
       (S3) NEBULIS.SUSP, 42/21.5.1/0955, 0956  inhal.3-4xdly.    CICLOVENT, Cipla Medpro [PWR]
       718677-001: 0,25 mg/ml, 20x2 ml unit dos.amps, R200,68  Therap.eff.achiev.aft.few days.  Ciclesonide.
       718678-001: 0,5 mg/ml, 20x2 ml unit dos.amps, R289,87  Contraindications: Pregn., ac.stat.asthmatic., pregn.  Indications: Asthma prophylax.in adults & adolesc.
       Dosage: Use only in nebulis. Not for inj. Indiv. titrat. to low.effect.  Side effects: Hoarsen., throat irrit., paradox. bronchosp., can-  (S3) PRESSUR.INHAL.SOL. 43/21.5.1/1168, 1169
       maint.dos.once asthma control achiev. Not intend.for rapid relief of   didias.of mouth & throat, poss. syst.corticoster.effs.with prolong./  721621-001: 80 µg/puff, 60 met.dos, R136,24
       ac.asthma episodes            excess.admin.                720711-001: 80 µg/puff, 120 met.dos, R272,49
       May be mix.with 0,9 % saline & sols.of terbutaline / salbutamol/  Special precautions: Teratogen.in animals, TB/ hist.thereof, im-  721620-001: 160 µg/puff, 60 met.dos, R224,98
       fenoterol/ acetylycysteine/sod. cromoglycate or ipratropium bromide   munosuppress.pts., discont. immed./ alter.ther.if bronchosp.occurs,   720735-001: 160 µg/puff, 120 met.dos, R449,96
       admix.to be used within 30 mins.  rinse mouth aft.use esp.with loc.Candida infects., not for ac.attacks,   Dosage: Inhalat.use only. Indiv.& titrat.to low. effect.dos.
       Asthma: Adults: Init. 0,5-1 mg 2xdly, may be furth. incr.in some cases.  reg.use essent., syst.ster.dur. stress, transf.from other anti-asthma   Adults & adolesc: Tot.dly.dos.range: 80-320 µg admin.as sngl.morn.
       Childr.12 mnths-6 yrs: Prev.ther: Recomm.start. dos. Bronchodilat.  ther., grad. reduct.in case of concom.syst.corticoster., intercurr. infects.  or even dos./in 2 div.dos.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page196.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page192.html">192</a>&nbsp;&nbsp;&nbsp;<a href="page193.html">193</a>&nbsp;&nbsp;&nbsp;<a href="page194.html">194</a>&nbsp;&nbsp;&nbsp;<a href="page195.html">195</a>&nbsp;&nbsp;&nbsp;<a href="page196.html">196</a>&nbsp;&nbsp;&nbsp;<a href="page197.html">197</a>&nbsp;&nbsp;&nbsp;<a href="page198.html">198</a>&nbsp;&nbsp;&nbsp;<a href="page199.html">199</a>&nbsp;&nbsp;&nbsp;<a href="page200.html">200</a>&nbsp;&nbsp;&nbsp;<a href="page201.html">201</a>&nbsp;&nbsp;&nbsp;<a href="page202.html">202</a>
             </td>
             <td width="35%"><a href="page198.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page198.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
